Assessment and Appraisal: Fundamental Aspects of Health Care Kent Woods Director, NHS Health Technology Assessment Programme.

Slides:



Advertisements
Similar presentations
Developing an Evaluation Strategy – experience in DFID Nick York Director – Country, Corporate and Global Evaluations, World Bank IEG Former Chief Professional.
Advertisements

European network for Health Technology Assessment | JA | To view drawing guides 1.Right-click on slide and select ’Grid and.
NICE and national clinical audit
Implementation of new technologies Dr Keith Cooper Southampton Health Technology Assessments Centre University of Southampton.
© IPA 2011 Governance Challenges in Healthcare Aidan Horan Institute of Public Administration 2 nd June 2011.
Patient Safety Conference National Clinical Effectiveness Committee
Evidence in action – moving from guidance to review
Development of an effectiveness evidence database and related evidence briefings.
Health Technology Assessment and evidence-informed decision making
Scottish Intercollegiate Guidelines Network (SIGN)
Value of information An innovative approach to prioritizing comparative effectiveness research AHRQ Annual Meeting September 29, 2010.
BALANCING EFFICIENCY AND EQUITY A NEW INTERNATIONAL RESEARCH PROGRAMME ADDRESSING THE ROLE OF VALUES IN HEALTH CARE Department of Primary Care and Public.
Undertaking Systematic Literature Reviews By Dr. Luke Pittaway Institute for Entrepreneurship and Enterprise Development.
Learning Resources for Health Conference 24th March 2009 NHS Evidence goes live 30 th April 2009 Anne Weist National Library for Health.
Cost-Effectiveness Analyses in the UK - Lessons from the National Institute for Clinical Excellence Mark Sculpher Professor of Health Economics Centre.
Michael Rawlins Chairman, National Institute for Health and Clinical Excellence, London Emeritus Professor, University of Newcastle upon Tyne Honorary.
Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.
Identifying evidence for decision-analytic models Suzy Paisley DoH Research Scientist in Evidence Synthesis Consensus Working Group on the Use of Evidence.
NICE, medtech and evidence Mrs Mirella Marlow MA MBA Programme Director MediWales 11 December 2012.
FAO/WHO CODEX TRAINING PACKAGE
The National Institute for Clinical Excellence in the UK – Experience and Impact Mark Sculpher Professor of Health Economics Centre for Health Economics.
The Use of Evidence in Economic Decision Models A NICE Perspective Dr Carole Longson Director Centre for Health Technology Evaluation National Institute.
From Evidence to EMS Practice: Building the National Model Eddy Lang, MD, CFPC (EM), CSPQ SMBD-Jewish General Hospital, McGill University Montreal, Canada.
Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases: Workshop Toleration.
IPhVWP Polish Presidency, Warsaw October 6 th 2011 Almath Spooner Irish Medicines Board Monitoring the outcome of risk minimisation activities.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.
Open Data Platform Supplier Forum 13 January 2012.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Performance Measurement and Analysis for Health Organizations
NHS Evidence…. …..and the NHS/HE partnership Dr Gillian Leng Chief Operating Officer, NHS Evidence Deputy Chief Executive NICE.
NICE: what it is and how it works Professor David Haslam, Chair, NICE 10 th June 2015.
Dr. Lai Fong Chiu Senior Research Fellow Institute of Health Sciences and Public Health Research University of Leeds Critical Engagement The Community.
Steph Garfield-Birkbeck Assistant Director NIHR Evaluation Trials and Studies Coordinating Centre, University of Southampton.
ARRA and HHS Data Policy Initiatives Academy Health NAHDO All Payer All Claims Data Bases James Scanlon, HHS Deputy Assistant Secretary/ASPE.
Evidence-Based Public Health Nancy Allee, MLS, MPH University of Michigan November 6, 2004.
Supporting tough decisions: linking Health technology assessment (HTA) and national priority setting in Norway Ånen Ringard 1, Berit Mørland 1,2 1 Secretariat.
Results The final report was presented to NICE and published by NICE and WHO. See
Themes Emerging from Country and Related Presentations Notes from session 1545 – 1730 Thursday 17 February 2011 Albert Weale.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
NICE social care quality standards National Care Association 28 September 2011.
Evidence serving practice: a perspective from WHO Regional Office for Europe Anca Dumitrescu, MD Director, Division of Information, Evidence and Communication.
Question-led mixed methods research synthesis Centre launch 21 June 2005 David Gough and Sandy Oliver Institute of Education, University of London.
Expanding the Capacity for Comparative Effectiveness Research
Structure Chief Executive Contracting and Performance System Management Director of Public Health Investment Planning Strategy, Planning and Involvement.
OR in Health: Looking back and looking forward Jim Chilcott YHORG Health & Social Services SIG Meeting 26th February 2009.
Introducing Unit Specifications and Unit Assessment Support Packs National 3 and 4 Business National 5 Business Management.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
HTA Efficient Study Designs Peter Davidson Head of HTA at NETSCC.
NICE Policy Update Michael Rawlins Chairman, National Institute for Health and Clinical Excellence, London Emeritus Professor, University of Newcastle.
Capacity Development Results Framework A strategic and results-oriented approach to learning for capacity development.
UK Clinical Research Network (UKCRN) UKCRN Training and Education (T&E) Update Dr Nicki Latham
Integrating Qualitative Research Into Health Technology Assessment in Canada The CADTH Experience Laura Weeks, PhD Scientific Advisor Kristen.
PHE Knowledge and Library Services – building an interactive evidence base Anne Brice Head of Knowledge & Library Services Public Health England.
Gwendolyn Ryals, Look at Me Artwork from The Creative Center Janey Shin, Director, Real World Evidence Government Affairs and Market Access CADTH Symposium.
The Workforce, Education Commissioning and Education and Learning Strategy Enabling world class healthcare services within the North West.
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
The Challenge of Getting Value in Health Care. Charles Normand, Edward Kennedy Professor of Health Policy and Management Trinity College Dublin.
Understanding Health Economics Nicola Cooper, PhD Professor of Healthcare Evaluation Research Department of Health Sciences University of Leicester
Introduction to NICE Professor David Haslam CBE,
Access and booking Productivity advice
Dr Peter Groves MD FRCP Consultant Cardiologist
An Introduction to the NIHR programmes
Systematic reviews and meta-analyses
Health Technology Assessment in India
Evidence-Based Public Health
Presentation transcript:

Assessment and Appraisal: Fundamental Aspects of Health Care Kent Woods Director, NHS Health Technology Assessment Programme

Key themes in health care The accelerating pace of health technology The interplay of science and judgement at all levels of health care The need for rigour in decision-making

Diagnostic technologies Radio immunoassay Flexible endoscopy Computerised tomography Diagnostic ultrasound Therapeutic technologies 1,106 new drugs marketed New devices (pacemakers, stents…..) New surgical procedures (transplantation, laparoscopy…)

Drugs

4S CARE WOSCOPS (statins £308m)

Percutaneous coronary intervention Coronary artery bypass grafting

What is HTA for? To supply the evidence base for those who plan, manage, provide or use health services in making decisions HTA does not make or determine the decisions HTA is needed at every level of health care

Assessment is a research activity and produces generalisable new knowledge ‘Appraisal’ applies that knowledge to specific local circumstances: –Applicability –Social values –Local priorities –Local resources Responding to the challenge of new technologies

Clarity (and accountability) of function Application of the right skills and competencies Assessments are transferable and replicable Why Separate Assessment and Appraisal?

HTA Programme NICE National Screening Committee NSCAG National: [Local commissioning] [Clinician/patient] AssessmentAppraisal

A methodology of appraisal The principles underlying decision-making have received less rigorous attention than the science, e.g: Equity? Priority? Efficiency? Individual preference/societal values?

HTA in Support of Appraisal NICE –40-50 TARs per year NSC –Systematic reviews on screening for prostate cancer, Down’s, HPV in cervical screening –RCTs on same topics NSCAG –ECMO trial; ventricular assist devices

1.Science informs, but does not dictate, decisions in health care 2.The scientific challenges are: –Synthesising evidence validly –Quantifying uncertainty –Communicating probabilities to those making decisions

Future issues for better decision-making Assessment –Synthesis from diverse study designs –Preserving transparency –Growing the research capacity Appraisal –Adapting to rapidly moving evidence –Developing and ‘selling’ explicit principles –Locating decisions at the right level